2024 Lundbeck Global
Golden Ticket
Apply by November 11, 2024
Lundbeck is sponsoring a competition to award one Golden Ticket at any BioLabs site in the US and Europe. Each Golden Ticket provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate early-stage startup working on research and development in pain disorders as described in the Eligibility Snapshot section below.
Golden Ticket Benefits
Eligibility Snapshot
Lundbeck is looking for an early-stage startup focused on therapeutics for prevention and/or treatment of head pain specifically as described below:
-
New therapeutics for prevention of severe migraine and other headache disorders such as cluster headache, post-traumatic headache, etc.​
-
New therapeutics for prevention of severe headache in definable patient sub-groups based on biological, genetics, symptoms and or comorbidities ​
-
New therapeutics for treatment of severe headache and/or prevention related to female-specific biological mechanisms e.g. in headache associated with oestrus (menstrual migraine) or menopause.​
-
New biomarker options for biologically definable severe headache patient sub-groups.
The Application Process
01
Submit applications by
November 11, 2024
02
A subset of applications will be identified as finalist by the contest judges by
November 25, 2024
03
Winning teams will present their company & scientific concept at a live event on
December 9, 2024
04
ONE award will be granted
Good luck!
Application Process
The official application process can be found above. Please read and verify your availability before submitting your application.
Contact Us
If you have any questions regarding this competition, contact goldenticket@lundbeck.com
​
If you have questions about BioLabs, contact goldenticket@biolabs.io
